by Thomas Rønn | Jan 25, 2021 | Other News
För 25 år sedan var han med och grundade Healthcap. Nu har Magnus Persson gjort det igen, med Eir Ventures, har han startat ett nytt bolag specialiserat på life science-investeringar. ”Sverige och Norden har länge visat sig fantastiskt när det gäller innovation”,...
by Thomas Rønn | Jan 23, 2021 | Articles
Q: Eir Ventures has now been in operations for 6 months since the launch last summer, how has that been? We were delighted to be able to reach the first close of Eir Ventures last summer. Obviously raising a new first time life science venture fund is never easy, and...
by Thomas Rønn | Jan 23, 2021 | Articles, Other News
Life sciences focused fund also announces first close of EUR76 million July 10, 2020, Stockholm & Copenhagen: Eir Ventures, a Nordic Life Science Venture Fund, today announced a first close of its new fund of EUR76 million. With a strong base in the Nordic region...
by Thomas Rønn | Jan 14, 2021 | Press Releases
Sortina Pharma AB today announces a financing led by the venture capital fund Eir Ventures and with GU Ventures, to unlock the potential of proprietary anti- sortilin cancer therapy to cure aggressive cancer. The founders of Sortina Pharma, Professor Göran Landberg...
by Thomas Rønn | Jan 13, 2021 | Press Releases
IO Biotech develops new cancer treatments, that have proven to give outstanding responses in combination with current standard of care in melanoma (skin cancer) and Non-small cell lung cancer. Eir Ventures is delighted to announce our participation in the over...
by Thomas Rønn | Sep 29, 2020 | Press Releases
Synklino is a Danish biotech company with technology from the University of Copenhagen and the Technical university of Denmark, focusing on developing groundbreaking therapies against devastating virus infections. Eir Ventures is happy to announce that we have lead...
by Thomas Rønn | Sep 25, 2020 | Press Releases
Eir Ventures co-leads high profile syndicate in €55 million investment in Galecto Biotech. The company is based on science and technology stemming from Swedish academia and developed in Denmark. The technology addresses fibrotic diseases with limited or no care...
by Thomas Rønn | Jul 10, 2020 | Press Releases
Life sciences focused fund also announces first close of EUR76 million July 10, 2020, Stockholm & Copenhagen: Eir Ventures, a Nordic Life Science Venture Fund, today announced a first close of its new fund of EUR76 million. With a strong base in the Nordic region...
Recent Comments